Evidence map›Paper›PMID 33648943›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2021

Interception Targets of

Su-Ni Tang, Peixin Jiang, Sangyub Kim, Jinhui Zhang, Cheng Jiang, Junxuan Lü

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Su-Ni TangSchool of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas.
Peixin JiangSchool of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas.
Sangyub KimDepartment of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania.
Jinhui ZhangSchool of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas.
Cheng JiangSchool of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas.
Junxuan LüSchool of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas. jxl1140@psu.edu.
Penn State Milton S. Hershey Medical Center · US

Funding

Mechanisms of prostate cancer prevention by Korean AngelicaR01AT007395 · NCCIH · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI LU, JUNXUAN · 2012 to 2016
$2.2M
PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUMR01CA172169 · NCI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI LU, JUNXUAN · 2013 to 2018
$1.6M
NCCIH NIH HHS R01 AT007395NCI NIH HHS R01 CA172169
6 · The paper itself

Abstract

We reported efficacy of

Indexed as

Administration, OralAngelicaAnimalsCarcinoma, NeuroendocrineDisease Models, AnimalGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMaleMiceMice, TransgenicPlant ExtractsPlant RootsProstatic NeoplasmsProtein Interaction MapsPyranocoumarinsPlant ExtractsPyranocoumarins

Identifiers

PMID33648943
PMCPMC8225574
OpenAlexW3135203826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.